Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.98
-0.01 (-0.14%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7.44 | 6.44 | 29.62 | 46.8 | 140.73 | 235.31 |
Revenue Growth | 6.35% | -78.26% | -36.71% | -66.74% | -40.19% | 33.46% |
Gross Profit Gross Profit Growth | 3.03 | 5.88 | 14.06 | 42.84 | 120.45 | 222.44 |
Operating Income Operating Income Growth | -44.79 | -45.9 | -150.42 | -322.72 | -301.03 | -288.53 |
Net Income Net Income Growth | 163.62 | 183.45 | -47.58 | -284.23 | -293.65 | -290.02 |
Earnings Per Share EPS Growth | 40.46 | 45.37 | -11.89 | -73.00 | -78.50 | -78.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | - | 26.11 | 12.96 | 12.52 | 46.12 |
Europe Europe Growth | 5.64 | 6.27 | 9.55 | 33.82 | 131.24 |
Japan Japan Growth | 0.8 | -2.85 | 15.87 | 9.76 | 2.31 |
China China Growth | - | 0.09 | 8.43 | 84.63 | 55.64 |
Total Total Growth | 6.44 | 29.62 | 46.8 | 140.73 | 235.31 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 87.24 | 88.98 | 50.48 | 203.45 | 422.01 | 405.19 |
Total Debt Total Debt Growth | 67.41 | 65.98 | 131.96 | 201.03 | 139.22 | 99.72 |
Net Cash (Debt) Net Cash Growth | 19.83 | 23 | -81.47 | 2.42 | 282.79 | 305.47 |
Net Cash Growth | - | - | - | -99.14% | -7.42% | -52.77% |
Net Cash Per Share Net Cash Per Share Growth | 4.90 | 5.69 | -20.36 | 0.62 | 75.55 | 82.69 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -21.38 | -4.77 | -138 | -315.02 | -145.93 | -82.23 |
Capital Expenditures CapEx Growth | -0.02 | -0.04 | -0.27 | -2.52 | -3.74 | -5.19 |
Free Cash Flow Free Cash Flow Growth | -21.4 | -4.81 | -138.27 | -317.54 | -149.67 | -87.42 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.70% | 91.37% | 47.47% | 91.53% | 85.59% | 94.53% |
Operating Margin | -602.14% | -712.65% | -507.80% | -689.53% | -213.90% | -122.62% |
Pretax Margin | -761.70% | -905.19% | -517.76% | -690.60% | -209.52% | -123.53% |
Profit Margin | -760.47% | -903.79% | -516.86% | -690.06% | -209.27% | -123.38% |
FCF Margin | -287.70% | -74.72% | -466.78% | -678.46% | -106.35% | -37.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 0.17 | 0.19 | - | - | - | - |
Forward PE | - | 201.74 | 201.74 | 201.74 | 201.74 | 201.74 |
PS Ratio | 3.80 | 5.52 | 1.80 | 1.87 | 10.72 | 5.57 |